In a blog post published this week, social network Facebook has revealed that it is making some tweaks to its algorithm, to bring about a change to the users' News Feed. As a result of the tweaked algorithm, stories will show up at the top of a user's News Feed in accordance with their actual relevance to the individual user.
Facebook said in its blog post that, with the help of the tweaked algorithm, it will be able to sift through Facebook posts and weed out the stories from the top of a user's feed if the stories are not of much interest to the user; irrespective of the number of likes and shares garnered by the story.
As such, Facebook will show up those stories on the top of a user's News feed which the users would likely want to see; and would probably click or 'like' the story, comment on it, or share the story with other users.
Towards that end, Facebook has asserted in its blog post: "We will rank stories higher in feed which we think people might take action on, and which people might want to see near the top of their News Feed."
With regard to the change being brought by Facebook to the users' News Feed, the company said that the move is based on the results of a survey, in which more than 1,000 Facebook users -- called the feed quality panel -- were paid to give a day-to-day rating to the quality of their News Feed.
There are a lot of things not going right at the IRS and mostly so when it comes to filing for Earned Income Tax Credits (EITC).
In December 2014, a report by Watchdog.org showed that that an audit by the IRS documented twenty four percent...
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies...
The Michael J Fox Foundation is aiming to test wearable sensors in smart watches made by Intel's...
There was a time just a few years back when Spain ranked second after Greece, as a figure of the euro zone's huge debt crisis and economic slowdown. The country's unemployment climbed to a huge twenty seven percent and the economy was still...
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in...
On Tuesday, tech giant Google released latest to show how much of its online traffic is...
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won't seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said...
On Thursday, the US Federal Bureau of Investigation (FBI...
In an announcement made via a blog post on Thursday,...
In a blog post published on Wednesday, Twitter-owned...
A draft New York legislation proposes the use of a...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).